Fibrosis Assessment in Myocardial Infarction-associated Ventricular Aneurysm

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorRenJi Hospital

About this trial

The study will use 18F-FAPI PET/CT to study myocardial fibrosis in patients diagnosed with myocardial infarction-associated ventricular aneurysm (MI-VA). Participants will receive the PET/CT scan during hospital stay, as well as serial echocardiography and telephonic follow-ups. Analysed will focus on the characterization of myocardial fibrosis and its correlations with the clinical prognosis in the patients.

Eligibility criteria

Qualifiers

Aged 18-75 years old

Diagnosed with STEMI or NSTEMI (ACC/AHA guidelines)

Half male and half female

Undergo CAG and PCI treatment;

Disqualifiers

Patients under the age of 18 years old;

Patients who are pregnant/breastfeeding;

Patients who has a previous history of allergy to radio tracers.

Trial design

Treatments tested in this trial

  • 18F FAPI-42 PET/CT scan

Treatment groups

20 Participants
are divided into 2 treatment groups

Sponsors and collaborators